avatar
zod***com05/30/2020 18:07

$VYNE Therapeutics Inc wasnt this drug FDA approved yesterday what am I missing The? What is June 2nd? "The FDA set a Prescription Drug User Fee Act action date of June 2nd, 2020.  If approved, FMX103 would be the first minocycline product available for rosacea patients. Foamix is also conducting a Phase II trial for FCD105, a topical combination foam of minocycline and adapalene, currently being evaluated for the treatment of moderate-to-severe acne vulgaris."

2
2
Risk Warning: All information and statistics provided on Webull website is for reference only. It does not represent an investment recommendation to stock, options and other investment products trading.
avatar
Share your ideas here…

All Comments

avatar
Dir***com·05/30/2020 23:38

the one is for acne the other is Rosacia

1
avatar
TraderJim·05/30/2020 23:24

conflicting news.. i'm pretty sure the report yestarday was accurate.. but we may yet see a second pop for those coming on board late thinking approval is still pending..

1
zod***com
7
Following
480
Post
0
Wefolios

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.

Copyright © 2021 Webull Technologies Limited All Rights Reserved